Live from the NIH registry
Studies recruiting near San Francisco right now
Top 25 of 2,236 recruiting studies, sorted by proximity — each links to its official registry page
QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer
HER2-positive Metastatic Breast Cancer
N/A
Observational 200 participants sought
University of California San Francisco Medical Center — San Francisco, California (1.9 mi)
· Sponsor: Abramson Cancer Center at Penn Medicine
Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections
Gonorrhea, Chlamydia
Phase 4
Interventional 760 participants sought
San Francisco Department of Public Health — San Francisco, California (1.9 mi)
· Sponsor: Westat
SWIR Otoscopy Study
Otitis Media, Otitis Media Chronic
N/A
Interventional 100 participants sought
Stanford University — Palo Alto, California (27.3 mi)
· Sponsor: Stanford University
A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease, GM1 Gangliosidosis or GM2 Gangliosidosis
Niemann-Pick Type C Disease, GM1 Gangliosidosis
Phase 3
Interventional 147 participants sought
UCSF Children's Hospital and Research Center at Oakland — Oakland, California (10.1 mi)
· Sponsor: Azafaros B.V.
Binimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant Melanoma
Melanoma Stage III, Melanoma Stage IV
Phase 2
Interventional 25 participants sought
University of California, San Francisco — San Francisco, California (1.9 mi)
· Sponsor: University of California, San Francisco
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
UCSF Medical Center-Mission Bay — San Francisco, California (1.9 mi)
· Sponsor: National Cancer Institute (NCI)
The Osteoporotic Fracture Classification-based Scoring System for Treatment Decision in Thoracolumbar Osteoporotic Fractures
Osteoporotic Fractures, Osteoporosis
N/A
Observational 648 participants sought
University of California San Francisco (USCF) Department of Orthopaedic Surgery — San Francisco, California (1.9 mi)
· Sponsor: AO Foundation, AO Spine
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
University of California San Francisco UCSF The Madison Clinic for Pediatric Diabetes — San Francisco, California (1.9 mi)
· Sponsor: Medtronic MiniMed, Inc.
Feasibility of Acquiring Hyperpolarized Imaging in Patients With Meningioma
Meningioma
Phase 1
Interventional 50 participants sought
University of California, San Francisco — San Francisco, California (1.9 mi)
· Sponsor: Javier Villaneuva-Meyer, MD
TBI Rehabilitation and Activation in Veterans
Traumatic Brain Injury
N/A
Interventional 120 participants sought
San Francisco VA Health Care System — San Francisco, California (1.9 mi)
· Sponsor: Northern California Institute of Research and Education
APPROVE Trial: Evaluating a Prescription Digital Therapeutic for Treatment of OAB in Women
Overactive Bladder (OAB), Urinary Urgency
N/A
Interventional 596 participants sought
Stanford University — Palo Alto, California (27.3 mi)
· Sponsor: Medstar Health Research Institute
HLA Demographics Study in Adults With Type 1 Diabetes
Diabetes Mellitus, Type I
N/A
Observational 200 participants sought
University of California, San Francisco — San Francisco, California (1.9 mi)
· Sponsor: GentiBio, Inc
Implementing Scalable, PAtient-centered, Team-based, Technology-enabled Care for Adults With Type 2 Diabetes (iPATH)
Diabetes Mellitus, Type 2
N/A
Interventional 119,680 participants sought
Board of Trustees of the Leland Stanford Junior University — Stanford, California (27.5 mi)
· Sponsor: Stanford University
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — San Francisco, California (1.9 mi)
· Sponsor: AstraZeneca
Exploring Clinical Utility of Wearables for the Bladder in Pelvic Health Physical Therapy Clinics
Postpartum Bladder Dysfunction, Post-prostatectomy Bladder Dysfunction
N/A
Observational 25 participants sought
University of California San Francisco Weill Institute for Neurosciences — San Francisco, California (1.9 mi)
· Sponsor: University of California, San Francisco
Moon and Sun Brothers: A Community Prevention Intervention (Hermanos de Luna y Sol)
Help-Seeking Behavior, Pre-exposure Prophylaxis Use
N/A
Interventional 360 participants sought
San Francisco State University — San Francisco, California (1.9 mi)
· Sponsor: San Francisco State University
KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)
Carcinoma, Non-Small-Cell Lung
Phase 1, Phase 2
Interventional 450 participants sought
UCSF Medical Center at Mission Bay ( Site 0007) — San Francisco, California (1.9 mi)
· Sponsor: Merck Sharp & Dohme LLC
Automated Insulin for Management of Intrapartum Glycemia
Type 1 Diabetes (T1D), Pregnancy
N/A
Interventional 150 participants sought
University of California, San Francisco — San Francisco, California (1.9 mi)
· Sponsor: University of California, San Francisco
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
University of California San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center — San Francisco, California (1.9 mi)
· Sponsor: Relay Therapeutics, Inc.
Feasibility of HPV Testing With Mail-delivered Sample Collection Kits
HPV Infection, HIV Infections
N/A
Observational 135 participants sought
University of California, San Francisco — San Francisco, California (1.9 mi)
· Sponsor: University of California, San Francisco
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
California Pacific Medical Center-Pacific Campus — San Francisco, California (1.9 mi)
· Sponsor: SWOG Cancer Research Network
Observational Study Protocol: LIVER-R
Hepatobiliary Cancers
N/A
Observational 4,490 participants sought
Research Site — Walnut Creek, California (23.2 mi)
· Sponsor: AstraZeneca
Treatment of Moderate to Severe Refractory Crohn's Disease
Crohns Disease
Phase 1, Phase 2
Interventional 39 participants sought
University of California, San Francisco — San Francisco, California (1.9 mi)
· Sponsor: Tr1X, Inc.
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Cystic Fibrosis (CF), Cystic Fibrosis-related Diabetes
N/A
Observational 200 participants sought
Stanford University — Palo Alto, California (27.3 mi)
· Sponsor: Jaeb Center for Health Research
Natural History of Medullary Thyroid Cancer to Inform Advanced Disease Management
Advanced Thyroid Gland Medullary Carcinoma, Stage III Thyroid Gland Medullary Carcinoma AJCC v8
N/A
Observational 2,030 participants sought
University of California San Francisco — San Francisco, California (1.9 mi)
· Sponsor: M.D. Anderson Cancer Center